glp-1 tri LY3437943, a novel triple glucagon, GIP, and receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept tri agonist glp 1 retatrutide

Taken together, these in vitro data suggest that indirect interference with RAS activity via dual SHP2/MEK inhibition leads to substantial metabolic changes in PDAC tumor cells

Item Form Capsule Primary Supplement Type L-Glutathione (Reduced) Flavor Unflavored Product Benefits Antioxidant Defense, Liver Detox, Skin Clarity, Immune Support Diet Type Gluten Free, Non-GMO Supplement Formulation Individual Supplement Best Taken With food, once daily Manufactured In USA, GMP-certified facility * These statements have not been evaluated by the Food and Drug Administration

Its not recommended, but plenty of people do it It's quite common for people to start on GLP-1 drugs like Ozempic and Zepbound, especially as the diabetes and obesity treatments become more ubiquitous

However, this connection was not definitively established